TY - JOUR
T1 - Ethnicity as a cultural factor influencing complete vaccination among children aged 12-23 months in Nigeria
AU - Afolabi, Rotimi Felix
AU - Salawu, Mobolaji M.
AU - Gbadebo, Babatunde Makinde
AU - Salawu, Adetokunbo T.
AU - Fagbamigbe, Adeniyi Francis
AU - Adebowale, Ayo Stephen
N1 - Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/19
Y1 - 2021/2/19
N2 - Achieving complete vaccination for children has been challenging in Nigeria. Yet, addressing Nigeria’s completeness of vaccination requires ethno-cultural diversity consideration rather than nationally population based. This study explored patterns and determinants of complete vaccination among children of Hausa/Fulani, Igbo and Yoruba, the predominant ethnicities in Nigeria. The study used a cross-sectional data involving 3980 children aged 12–23 months extracted from the 2018 Nigeria Demographic and Health Survey dataset. In this study, complete vaccination is defined as a child who received all recommended vaccinations. A generalized linear mixed model applied to clustered data was used for data analysis (α = 0.05). The prevalence of complete vaccinations was 56.3%, 40.8% and 18.2% among Igbo, Yoruba and Hausa/Fulani children, respectively. The likelihood of complete vaccination was higher among children who were of Igbo (aOR = 1.38; CI: 1.20–1.59) compared with Hausa/Fulani. Predictors of complete vaccination were maternal age-at-childbirth, education, prenatal-care attendant and place of delivery among Hausa/Fulani; place of residence and perceived access to self-medical help, among Igbo; while prenatal-care attendance, among Yoruba. The odds of complete vaccination were higher among Hausa/Fulani (aOR = 1.65; CI: 1.04–2.61), Igbo (aOR = 2.55; CI: 1.20–5.44) and Yoruba (aOR = 4.22; CI: 1.27–13.96) children from higher wealth-quintile households compared to those from poor households. There was evidence of variability in the likelihood of complete vaccination in all the ethnic groups. The Hausa/Fulani tribe had the lowest complete vaccination coverage for children aged 12–23 months. Context-specific program intervention to improve complete vaccination is needed to ensure that the SDG target for vaccination is met.
AB - Achieving complete vaccination for children has been challenging in Nigeria. Yet, addressing Nigeria’s completeness of vaccination requires ethno-cultural diversity consideration rather than nationally population based. This study explored patterns and determinants of complete vaccination among children of Hausa/Fulani, Igbo and Yoruba, the predominant ethnicities in Nigeria. The study used a cross-sectional data involving 3980 children aged 12–23 months extracted from the 2018 Nigeria Demographic and Health Survey dataset. In this study, complete vaccination is defined as a child who received all recommended vaccinations. A generalized linear mixed model applied to clustered data was used for data analysis (α = 0.05). The prevalence of complete vaccinations was 56.3%, 40.8% and 18.2% among Igbo, Yoruba and Hausa/Fulani children, respectively. The likelihood of complete vaccination was higher among children who were of Igbo (aOR = 1.38; CI: 1.20–1.59) compared with Hausa/Fulani. Predictors of complete vaccination were maternal age-at-childbirth, education, prenatal-care attendant and place of delivery among Hausa/Fulani; place of residence and perceived access to self-medical help, among Igbo; while prenatal-care attendance, among Yoruba. The odds of complete vaccination were higher among Hausa/Fulani (aOR = 1.65; CI: 1.04–2.61), Igbo (aOR = 2.55; CI: 1.20–5.44) and Yoruba (aOR = 4.22; CI: 1.27–13.96) children from higher wealth-quintile households compared to those from poor households. There was evidence of variability in the likelihood of complete vaccination in all the ethnic groups. The Hausa/Fulani tribe had the lowest complete vaccination coverage for children aged 12–23 months. Context-specific program intervention to improve complete vaccination is needed to ensure that the SDG target for vaccination is met.
UR - http://www.scopus.com/inward/record.url?scp=85101152661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101152661&partnerID=8YFLogxK
U2 - 10.1080/21645515.2020.1870394
DO - 10.1080/21645515.2020.1870394
M3 - Article
AN - SCOPUS:85101152661
SN - 2164-5515
VL - 17
SP - 2008
EP - 2017
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 7
ER -